Sb Pharmco Drug Patent Portfolio
Sb Pharmco owns 2 orange book drugs protected by 9 US patents Given below is the list of Sb Pharmco's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8236345 | Composition and use | 07 Oct, 2022 | Expired |
| US7358366 | Thiazolidinedione derivative and its use as antidiabetic | 19 Oct, 2020 | Expired |
| US7358366 | Thiazolidinedione derivative and its use as antidiabetic | 19 Apr, 2020 | Expired |
| US6288095 | Compounds | 11 Aug, 2017 | Expired |
| US6288095 | Compounds | 11 Feb, 2017 | Expired |
| US5965584 | Pharmaceutical composition | 19 Jun, 2016 | Expired |
| US6166042 | Pharmaceutical composition | 19 Jun, 2016 | Expired |
| US5741803 | Substituted thiazolidinedionle derivatives | 21 Oct, 2015 | Expired |
| US5741803 | Substituted thiazolidinedionle derivatives | 21 Apr, 2015 | Expired |
Latest Legal Activities on Sb Pharmco's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Sb Pharmco.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Maintenance Fee Reminder Mailed
Critical
| 25 Mar, 2024 | US8236345 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 16 Jan, 2020 | US8236345 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Aug, 2012 | US8236345 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Aug, 2012 | US8236345 |
|
Issue Notification Mailed
Critical
| 18 Jul, 2012 | US8236345 |
| Dispatch to FDC | 06 Jul, 2012 | US8236345 |
|
Application Is Considered Ready for Issue
Critical
| 06 Jul, 2012 | US8236345 |
|
Issue Fee Payment Received
Critical
| 05 Jul, 2012 | US8236345 |
|
Issue Fee Payment Verified
Critical
| 05 Jul, 2012 | US8236345 |
|
Expire Patent
Critical
| 14 May, 2012 | US7358366 |
|
Expire Patent
Critical
| 14 May, 2012 | US7358366 |
|
Mail Notice of Allowance
Critical
| 05 Apr, 2012 | US8236345 |
|
Notice of Allowance Data Verification Completed
Critical
| 26 Mar, 2012 | US8236345 |
| Date Forwarded to Examiner | 28 Dec, 2011 | US8236345 |
| Disposal for a RCE / CPA / R129 | 28 Dec, 2011 | US8236345 |
Sb Pharmco's Family Patents
Sb Pharmco Drug List
Given below is the complete list of Sb Pharmco's drugs and the patents protecting them.
1. Avandamet
Avandamet is protected by 9 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8236345 | Composition and use |
07 Oct, 2022
(2 years ago)
| Expired |
| US7358366
(Pediatric)
| Thiazolidinedione derivative and its use as antidiabetic |
19 Oct, 2020
(4 years ago)
| Expired |
| US7358366 | Thiazolidinedione derivative and its use as antidiabetic |
19 Apr, 2020
(5 years ago)
| Expired |
| US6288095
(Pediatric)
| Compounds |
11 Aug, 2017
(7 years ago)
| Expired |
| US6288095 | Compounds |
11 Feb, 2017
(8 years ago)
| Expired |
| US5965584 | Pharmaceutical composition |
19 Jun, 2016
(8 years ago)
| Expired |
| US6166042 | Pharmaceutical composition |
19 Jun, 2016
(8 years ago)
| Expired |
| US5741803
(Pediatric)
| Substituted thiazolidinedionle derivatives |
21 Oct, 2015
(9 years ago)
| Expired |
| US5741803 | Substituted thiazolidinedionle derivatives |
21 Apr, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Avandamet's drug page
2. Avandaryl
Avandaryl is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7358366
(Pediatric)
| Thiazolidinedione derivative and its use as antidiabetic |
19 Oct, 2020
(4 years ago)
| Expired |
| US7358366 | Thiazolidinedione derivative and its use as antidiabetic |
19 Apr, 2020
(5 years ago)
| Expired |
| US5741803
(Pediatric)
| Substituted thiazolidinedionle derivatives |
21 Oct, 2015
(9 years ago)
| Expired |
| US5741803 | Substituted thiazolidinedionle derivatives |
21 Apr, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Avandaryl's drug page